Pfizer: A Dose of Defense in a Feel-Good Market
[vc_row css=”.vc_custom_1655497862601{padding-top: 40px !important;padding-right: 60px !important;padding-left: 60px !important;}”][vc_column][vc_column_text] As the market has rallied to record levels in recent weeks, Pfizer has enjoyed the ride, and then some. The pharmaceutical giant is up about 12% compared with 9% for the Standard & Poor’s 500. Yet unlike many other stocks trading at 52-week highs (or better), the […]
Pfizer: A Dose of Defense in a Feel-Good Market Read More »